{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:04:53Z","timestamp":1773327893169,"version":"3.50.1"},"reference-count":105,"publisher":"American Speech Language Hearing Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Audiol"],"published-print":{"date-parts":[[2020,12,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Over the last two decades, the number of Americans misusing opioids has reached epidemic levels. With such drastic increases in opioid misuse, audiologists are more likely to have patients with opioid-induced hearing loss or neonatal abstinence syndrome (NAS) than in previous years. More attention is needed on how these increases might influence clinical practice and such a discussion could be useful for audiologists. The goal of this article, therefore, is to summarize what is currently known regarding the relationship between opioid misuse and audiology to help guide hearing health care providers (with a particular focus on opioid-induced hearing loss and NAS). This article (a) summarizes the overlap in opioid misuse and hearing loss populations, (b) describes the evidence linking opioid misuse to hearing loss, (c) discusses clinical implications that opioid-induced hearing loss and NAS have for practicing audiologists, and (d) recommends directions for future audiological research on opioid-induced hearing loss and NAS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>There is considerable overlap between populations at-risk for hearing loss and opioid misuse. Additionally, compelling evidence exists linking opioid misuse to hearing loss, but the specific causal mechanisms remain unclear, indicating a need for additional research. This article attempts to fill a gap in the audiological literature and has the potential to serve as a guide for hearing health care providers to make more informed clinical decisions regarding patients with opioid-induced hearing loss and NAS. Clinicians may wish to consider the concerns raised in this article before intervening with such concerns, especially in the absence of best practice protocols.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1044\/2020_aja-20-00054","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:24:32Z","timestamp":1603931072000},"page":"701-709","source":"Crossref","is-referenced-by-count":10,"title":["Opioid-Induced Hearing Loss and Neonatal Abstinence Syndrome: Clinical Considerations for Audiologists and Recommendations for Future Research"],"prefix":"10.1044","volume":"29","author":[{"given":"Khary K.","family":"Rigg","sequence":"first","affiliation":[{"name":"Department of Mental Health Law and Policy, University of South Florida, Tampa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malika S.","family":"Rigg","sequence":"additional","affiliation":[{"name":"Department of Audiology, James A. Haley Veterans' Hospital, Tampa, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1310","reference":[{"key":"e_1_3_1_2_1","volume-title":"Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities 2003\u20132015 (updated)","author":"Alderks C.","year":"2017"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.02.023"},{"issue":"4","key":"e_1_3_1_4_1","article-title":"Deafness associated with acetaminophen and codeine abuse","volume":"37","author":"Blakley B. W.","year":"2008","journal-title":"Journal of Otolaryngology\u2013Head & Neck Surgery"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.04.005"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.370"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2014.930372"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1044\/leader.FTR2.23112018.50"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2013.01.003"},{"key":"e_1_3_1_10_1","unstructured":"Center for Behavioral Health Statistics and Quality. (2018). Results from the 2017 National Survey on Drug Use and Health: Detailed tables. \nhttps:\/\/www.samhsa.gov\/data\/report\/2017-nsduh-detailed-tables"},{"key":"e_1_3_1_11_1","unstructured":"Centers for Disease Control and Prevention. (2018). CDC Wide-range Online Data for Epidemiological Research (WONDER). \nhttps:\/\/wonder.cdc.gov"},{"key":"e_1_3_1_12_1","unstructured":"Centers for Disease Control and Prevention. (2020). Data and statistics about opioid use during pregnancy. \nhttps:\/\/www.cdc.gov\/pregnancy\/opioids\/data.html"},{"key":"e_1_3_1_13_1","unstructured":"Center for Ethics and Rule of Law. (2017). Report on the intersection of opioid overuse and Veteran mental health challenges. \nhttps:\/\/www.law.upenn.edu\/live\/files\/6192-cerl-report-on-ptsd-and-opioid-addiction-final"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599819859885"},{"key":"e_1_3_1_15_1","volume-title":"State variation in medicaid prescriptions for opioid use disorder from 2011 to 2018. The Urban Institute Health Policy Center","author":"Clemans-Cape L.","year":"2019"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2004.04.021"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-3289(01)00073-6"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.22827"},{"key":"e_1_3_1_19_1","unstructured":"Department of Veterans Affairs. (2018). Fact sheet for audiology services. \nhttps:\/\/www.prosthetics.va.gov\/factsheet\/Audiology-FactSheet.pdf"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.71.11.897"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1179\/1077352512Z.0000000004"},{"key":"e_1_3_1_22_1","unstructured":"Drug Enforcement Administration. (2020). Narcotics: Opioids. \nhttps:\/\/www.dea.gov\/taxonomy\/term\/331"},{"key":"e_1_3_1_23_1","unstructured":"Ehlers J. J.\n (2018). Hearing loss and hearing protection use among midwestern farmers. \nhttps:\/\/digitalcommons.unmc.edu\/cgi\/viewcontent.cgi?article=1337&context=etd"},{"issue":"2","key":"e_1_3_1_24_1","first-page":"188","article-title":"Profound hearing loss associated with hydrocodone\/acetaminophen abuse","volume":"21","author":"Friedman R. A.","year":"2000","journal-title":"Otology & Neurotology"},{"issue":"6","key":"e_1_3_1_25_1","first-page":"1099","article-title":"Prescription opioid misuse among adolescents","volume":"66","author":"Ford J. A.","year":"2019","journal-title":"Pediatric Clinics"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11121-014-0514-y"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.3766\/jaaa.19.6.2"},{"key":"e_1_3_1_28_1","volume-title":"VA's opiate overload feeds veterans' addictions, overdose deaths","author":"Glantz A.","year":"2013"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310051170"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v23n04_01"},{"key":"e_1_3_1_31_1","unstructured":"Healthcare Cost and Utilization Project. (2016). Neonatal abstinence syndrome (NAS) among newborn hospitalization. \nhttps:\/\/www.hcup-us.ahrq.gov\/faststats\/NASMap"},{"key":"e_1_3_1_32_1","unstructured":"House Ear Institute. (2017). Medications that can cause deafness. \nhttps:\/\/hei.org\/wp-content\/uploads\/2020\/04\/HC-Magazine-Final.pdf"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.1068"},{"issue":"9","key":"e_1_3_1_34_1","first-page":"1363","article-title":"Heroin-induced reversible profound deafness and vestibular dysfunction","volume":"96","author":"Ishiyama A.","year":"2001","journal-title":"Addiction"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2014.0128"},{"key":"e_1_3_1_36_1","first-page":"467","article-title":"Hydrocodone use and sensorineural hearing loss","volume":"10","author":"Ho T.","year":"2007","journal-title":"Pain Physician"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0023992"},{"issue":"2","key":"e_1_3_1_38_1","first-page":"1","article-title":"Principles and guidelines for early hearing detection and intervention programs","volume":"4","author":"Joint Committee on Infant Hearing","year":"2019","journal-title":"Journal of Early Hearing Detection and Intervention"},{"key":"e_1_3_1_39_1","unstructured":"Johns Hopkins Medicine. (2020). Opioid addiction: What are opioids. \nhttps:\/\/www.hopkinsmedicine.org\/opioids\/what-are-opioids.html"},{"key":"e_1_3_1_40_1","volume-title":"Occupational exposure to chemicals and hearing impairment, 142","author":"Johnson A. C.","year":"2010"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.10.009"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2018.06.005"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204261004000403"},{"issue":"3","key":"e_1_3_1_44_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.297.3.249","article-title":"Opioid prescriptions soar: Increase in legitimate use as well as abuse","volume":"297","author":"Kuehn B. M.","year":"2007","journal-title":"Journal of American Medical Association"},{"key":"e_1_3_1_45_1","first-page":"2017","author":"Kochanek K. D.","year":"2019","journal-title":"National vital statistics reports: Deaths: Final data for"},{"key":"e_1_3_1_46_1","first-page":"4","article-title":"Opioid induced hearing loss: A trend to keep listening for?","volume":"44","author":"Kopec K. T.","year":"2012","journal-title":"Emergency Medicine"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-504X.2005.00359.x"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10389"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.23031"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.1390"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1315724"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1037\/tra0000269"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.3109\/14992020309074624"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1891\/0730-0832.32.6.409"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1089\/10872910260066697"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6515a2"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.22082"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1605"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.128504"},{"issue":"5","key":"e_1_3_1_60_1","first-page":"327","article-title":"Mutual mistrust in the medical care of drug users","volume":"17","author":"Merrill J. O.","year":"2002","journal-title":"Journal of General Internal Medicine"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/deafed\/ent034"},{"key":"e_1_3_1_62_1","first-page":"57","article-title":"Chemical interactions in the auditory system: Implications for occupational health","author":"Morata T. C.","year":"2010","journal-title":"Synergistic Exposure to Noise, Vibrations and Ototoxic Substances"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-020-00785-5"},{"issue":"5","key":"e_1_3_1_64_1","first-page":"435","article-title":"Sudden binaural deafness after acute heroin intoxication","volume":"58","author":"Mulch G.","year":"1979","journal-title":"Laryngologie, Rhinologie, Otologie"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1044\/1059-0889(2010\/09-0020)"},{"key":"e_1_3_1_66_1","unstructured":"National Institute on Drug Abuse. (2019). Dramatic increases in maternal opioid use and neonatal abstinence syndrome. \nhttps:\/\/www.drugabuse.gov\/drug-topics\/trends-statistics\/infographics\/dramatic-increases-in-maternal-opioid-use-neonatal-abstinence-syndrome"},{"key":"e_1_3_1_67_1","unstructured":"National Institute on Drug Abuse. (2020). Opioids: Summary of the issue. \nhttps:\/\/www.drugabuse.gov\/drug-topics\/opioids"},{"key":"e_1_3_1_68_1","unstructured":"National Institute on Deafness and Other Communication Disorders. (2016). Fact sheet: Age-related hearing loss. \nhttps:\/\/www.nidcd.nih.gov\/sites\/default\/files\/Documents\/health\/hearing\/AgeRelatedHearingLoss.pdf"},{"issue":"4","key":"e_1_3_1_69_1","first-page":"412","article-title":"Tinnitus in elderly population: Clinic correlations and impact upon QoL","volume":"4","author":"Negrila-Mezei A.","year":"2011","journal-title":"Journal of Medicine and Life"},{"key":"e_1_3_1_70_1","article-title":"Review of opioid-associated hearing loss and possible mechanism of opioid-mediated endothelin-1-dependent cochlear vasoconstriction","volume":"3","author":"Nguyen K. D.","year":"2014","journal-title":"Journal of Otology and Rhinology"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.12.2345"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107640"},{"issue":"1","key":"e_1_3_1_73_1","first-page":"64","article-title":"Opioid drugs and sensorineural hearing loss","volume":"10","author":"Oroei M.","year":"2018","journal-title":"Addiction & Health"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204260603600409"},{"key":"e_1_3_1_75_1","first-page":"57","article-title":"Sensorineural hearing loss in a heroin addict","volume":"67","author":"Polpathapee S.","year":"1984","journal-title":"Journal of the Medical Association of Thailand"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1044\/leader.FTR1.23112018.42"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1954"},{"issue":"12","key":"e_1_3_1_78_1","first-page":"1383","article-title":"Bilateral pallidal and medial temporal lobe ischaemic lesions after opioid overdose","volume":"86","author":"Ramirez-Zamora A.","year":"2015","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1192\/apt.bp.106.002840"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.4103\/1463-1741.99896"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13282.x"},{"issue":"6","key":"e_1_3_1_82_1","first-page":"E161","article-title":"Profound hearing loss associated with oxycodone-acetaminophen abuse","volume":"37","author":"Rigby M. H.","year":"2008","journal-title":"Journal of Otolaryngology-Head & Neck Surgery"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1080\/21635781.2014.917011"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.06.004"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2019.1609336"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.04.011"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-012-9426-x"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HJ.0000503462.28341.2a"},{"key":"e_1_3_1_89_1","first-page":"430","volume-title":"Auditory processing deficits: Assessment and intervention","author":"Rawool V. W.","year":"2016"},{"key":"e_1_3_1_90_1","volume-title":"Skills for effective counseling: A faith-based integration","author":"Sbanotto E. A. N.","year":"2016"},{"key":"e_1_3_1_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2016.04.020"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826089509071057"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-007-0495-6"},{"key":"e_1_3_1_94_1","doi-asserted-by":"publisher","DOI":"10.3766\/jaaa.22.4.3"},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2010.11.014"},{"issue":"8","key":"e_1_3_1_96_1","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle J. M.","year":"2006","journal-title":"American Family Physician"},{"key":"e_1_3_1_97_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1376685"},{"key":"e_1_3_1_98_1","unstructured":"Terrie Y\n. (2011). An overview of opioids. \nhttps:\/\/www.pharmacytimes.com\/publications\/issue\/2011\/June2011\/An-Overview-of-Opioids"},{"key":"e_1_3_1_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1500439"},{"key":"e_1_3_1_100_1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1212"},{"key":"e_1_3_1_101_1","unstructured":"Weiss A. J. Elixhauser A. Barrett M. L. Steiner C. A. Bailey M. K. & \nO'Malley L.\n (2014). Opioid-related inpatient stays and emergency department visits by state 2009\u20132014. HCUP Statistical Brief #219. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb219- Opioid-Hospital-Stays-ED-Visits-by-State.jsp"},{"key":"e_1_3_1_102_1","unstructured":"Weiss A. J. Heslin K. C. Barrett M. L. Izar R. & \nBierman A. S.\n (2018). Opioid-related inpatient stays and emergency department visits among patients aged 65 years and older 2010 and 2015: Statistical Brief #244. \nhttps:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb244-Opioid-Inpatient-Stays-ED-Visits-Older-Adults.jsp"},{"key":"e_1_3_1_103_1","doi-asserted-by":"publisher","DOI":"10.4103\/1463-1741.149574"},{"key":"e_1_3_1_104_1","unstructured":"White House Council of Economic Advisers. (2017). The underestimated cost of the opioid crisis. \nhttps:\/\/www.whitehouse.gov\/sites\/whitehouse.gov\/files\/images\/The%20Underestimated%20Cost%20of%20the%20Opioid%20Crisis.pdf"},{"key":"e_1_3_1_105_1","unstructured":"Wilkie R\n. (2018). United States White House: Fighting pain and addiction for Veterans. \nhttps:\/\/www.whitehouse.gov\/articles\/fighting-pain-addiction-veterans"},{"issue":"1","key":"e_1_3_1_106_1","first-page":"1","article-title":"A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers","volume":"268","author":"Zacny J. P.","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["American Journal of Audiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.asha.org\/doi\/pdf\/10.1044\/2020_AJA-20-00054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T21:31:14Z","timestamp":1618781474000},"score":1,"resource":{"primary":{"URL":"http:\/\/pubs.asha.org\/doi\/10.1044\/2020_AJA-20-00054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12,9]]}},"alternative-id":["10.1044\/2020_AJA-20-00054"],"URL":"https:\/\/doi.org\/10.1044\/2020_aja-20-00054","relation":{},"ISSN":["1059-0889","1558-9137"],"issn-type":[{"value":"1059-0889","type":"print"},{"value":"1558-9137","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]}}}